Literature DB >> 26698198

Cannabinoid hyperemesis syndrome: a guide for the practising clinician.

Sanjin Bajgoric1, Kiran Samra1, Subashini Chandrapalan1, Nishant Gautam1.   

Abstract

Cannabis is the most widely used illicit drug in the world. The medicinal value of cannabis as an antiemetic is well known by the medical fraternity. A less well-recognised entity is the potential for certain chronic users to develop hyperemesis. We describe the case of a young man who presented to us with features of cannabinoid hyperemesis syndrome. We review the current literature on this condition, its pathogenesis and management. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26698198      PMCID： PMC4691917          DOI： 10.1136/bcr-2015-210246

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  15 in total

1.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  The functional gastrointestinal disorders and the Rome III process.

Authors:  Douglas A Drossman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 3.  Cannabinoid hyperemesis.

Authors:  Stephen Sullivan
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

4.  [Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance].

Authors:  J Bramstedt; R Dissmann
Journal:  Dtsch Med Wochenschr       Date:  2011-08-29       Impact factor: 0.628

5.  Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.

Authors:  Siva P Sontineni; Sanjay Chaudhary; Vijaya Sontineni; Stephen J Lanspa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

6.  Cannabinoid hyperemesis: a case series.

Authors:  Michael W Donnino; Michael N Cocchi; Joseph Miller; Jonathan Fisher
Journal:  J Emerg Med       Date:  2009-09-17       Impact factor: 1.484

7.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Cannabinoid hyperemesis relieved by compulsive bathing.

Authors:  Yoon Hee Chang; Donna M Windish
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

9.  Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use.

Authors:  Benjamin Cox; Akansha Chhabra; Michael Adler; Justin Simmons; Diana Randlett
Journal:  Case Rep Med       Date:  2012-05-28

10.  Association of marijuana use and cyclic vomiting syndrome.

Authors:  Mithun B Pattathan; Reza A Hejazi; Richard W McCallum
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-29
View more
  4 in total

1.  A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options.

Authors:  Helen Senderovich; Preet Patel; Briam Jimenez Lopez; Sarah Waicus
Journal:  Med Princ Pract       Date:  2021-11-01       Impact factor: 1.927

2.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598

Review 3.  Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.

Authors:  Asim Kichloo; Michael Albosta; Michael Aljadah; Zain El-Amir; Ghazaleh Goldar; Muhammed Zatmar Khan; Dushyant Singh Dahiya; Srilakshmi Vallabhaneni; Farah Wani; Jagmeet Singh
Journal:  SAGE Open Med       Date:  2021-03-09

4.  A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong.

Authors:  Helen Senderovich; Sarah Waicus
Journal:  Oncol Res Treat       Date:  2022-05-03       Impact factor: 2.844
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.